MRI company pays $3.57 million for false claims

MRI公司支付$3.57百万错误要求

Carol Ko, Staff Writer | September 10, 2013
The U.S. Department of Justice announced last Tuesday that New York-based MRI diagnostic company Imagimed has agreed to pay $3.57 million over allegations of false claims for MRI exams.

From July 1, 2001, through April 23, 2008, the company allegedly submitted Medicare and Medicaid claims for MRI scans performed with a contrast agent, without the supervision of a qualified physician.

Federal regulations require that scans using contrast agents be supervised because they may cause the patient to go into anaphylactic shock.

Servicing GE, Philips and Siemens CT equipment with OEM trained engineers

Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.

The company also allegedly submitted claims referred by physicians with whom it had "improper financial relationships," according to the Department of Justice.

In exchange for these referrals, Imagimed provided kickbacks and gifts.

"Stripping away the profit motive for circumventing physician supervision requirements has both a remedial and a deterrent effect. The settlement announced today advances our critical interest in both the integrity of our health care system and the safe delivery of medical services," U.S. Attorney for the Northern District of New York, Richard S. Hartunian, said in a statement.

The case illustrates a renewed effort on the government's part to focus on health care fraud — a relevant concern in light of rising health care costs.

In 2009, the Justice Department and the Department of Health and Human Services received $198 million to crack down on health care fraud. Between 2009 and 2011, the federal government has collected $7.20 for every dollar spent on fighting fraud, according to the Department of Health and Human Services.

Imagimed did not respond to a request for comment as of Monday.

You Must Be Logged In To Post A Comment